Takeda N, Tanamura A, Iwai T, Nakamura I, Kato M, Ohkubo T, Noma K
Department of Internal Medicine, Aoto Hospital, Jikei University School of Medicine, Tokyo, Japan.
Mol Cell Biochem. 1993 Feb 17;119(1-2):105-8. doi: 10.1007/BF00926860.
Mutation of myocardial mitochondrial DNA was investigated in human left ventricles obtained at autopsy using the polymerase chain reaction (PCR). Seventeen autopsy cases were examined, including patients with diabetes mellitus, myocardial infarction, cardiomyopathy, cancer, and other diseases. Two cases of diabetes mellitus, 2 of myocardial infarction, and 1 of pulmonary fibrosis showed a 7.4 kb deletion of myocardial mitochondrial DNA. Primer shift PCR confirmed that an amplified DNA fragment had not been obtained by misannealing of the primers. It is unclear how much these findings are related to the severity or prognosis of the various diseases, but they indicate that mutation of myocardial mitochondrial DNA can occur in other diseases besides cardiomyopathy, although the influence of aging could not be excluded.
利用聚合酶链反应(PCR)对尸检获得的人类左心室心肌线粒体DNA突变情况进行了研究。共检查了17例尸检病例,包括糖尿病、心肌梗死、心肌病、癌症及其他疾病患者。2例糖尿病患者、2例心肌梗死患者和1例肺纤维化患者的心肌线粒体DNA出现7.4 kb缺失。引物移位PCR证实,未因引物错配而获得扩增的DNA片段。目前尚不清楚这些发现与各种疾病的严重程度或预后有多大关联,但它们表明,除心肌病外,心肌线粒体DNA突变也可能发生在其他疾病中,不过衰老的影响也不能排除。